Tag: Vazalore

PLx Pharma Inc. Announces New Scientific Data Available Evaluating the Pharmacologic Profile of FDA-Approved VAZALORE 81 mg Liquid-Filled Aspirin Capsules

— VAZALORE 81 mg shows fast bioavailability, absorption, and platelet inhibition — — VAZALORE 81 mg has pharmacokinetic and pharmacodynamic profiles consistent with VAZALORE 325 mg — — Findings presented at TCT meeting earlier today — SPARTA, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” […]